Probitas Pharma Inc located in Los Angeles is dedicated to Others and you can find it at 2410 Lillyvale Ave, Los Angeles, 90032, CA - California - United States or by phone numbers +1 323 225 2221, if you wish you can contact Probitas Pharma Inc during office hours exposed below on this page or by completing the contact form from Probitas Pharma Inc 24 hours a day. Remember that in asdphone.com we offer you telephone numbers, address, opening hours and other information more that might interest you.
Probitas Pharma Inc is registered in the categories: Others
Summary Probitas Pharma Inc Others in Los Angeles
2410 Lillyvale Ave, Los Angeles, 90032, CA - California - United States
comment Write review
- keyboard_arrow_right Share your experiences!
- location_onDays and Hours of Service Probitas Pharma Inc Others in Los Angeles
Data not supplied by the company - location_onAddress Probitas Pharma Inc Others in Los Angeles
2410 Lillyvale Ave, Los Angeles, 90032, CA - California - United States
How to get? - person_pinContact person
Hidden
- callPhones Probitas Pharma Inc Others in Los Angeles
- emailSend email to Probitas Pharma Inc Others in Los Angeles
- paymentPayment Methods
I am the owner or representative
Probitas Pharma Inc Others in Los Angeles: This business has not yet been claimed by the owner or a representative. Claim this business to view business statistics, receive messages from prospective customers, and respond to reviews.
Reclaim business business
Advertise in the commercial network. We are more than 10 million. You can advertise your business, sell products or services, search job and much more
asdphone.com does not represent, nor, therefore, guarantees or endorses the accuracy and veracity of the information, content or advertisements included, distributed, linked, downloaded or obtained from Probitas Pharma Inc, nor the quality of any of the products, information or other exhibited elements, acquired or obtained as a result of the publicity or any other information or offer available in or in relation to Probitas Pharma Inc More information